Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Exec departure
confidence 95%
filed 2026-08-19
EX-99.1
The exhibit announces the departure of Chief Financial Officer Eyal Rubin, who "will be leaving the Company to pursue a new opportunity outside of the life science industry" effective September 18, 2026. Simultaneously, Oren Elmaliach, the Director of Finance, has been appointed Interim Chief Financial Officer. The primary disclosed action is Rubin's departure from a named executive officer role, making this an exec_departure event. The CFO transition at a clinical-stage pharmaceutical company is material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-19
Item 2.02
This is a clear earnings release for fiscal Q3 2026 (ended June 30, 2026) filed under Item 2.02. The press release (Exhibit 99.1) discloses quarterly financial results including net sales of $3.4 million (27% YoY growth), operating loss of $3.2 million (63% improvement YoY), net loss from continuing operations of $4.1 million (40% improvement YoY), and detailed balance sheet metrics including NAV of $62.9 million or $3.22 per share. The filing includes unaudited condensed consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-19
GameSquare filed a Certificate of Amendment on August 18, 2026, implementing a 1-for-8 reverse stock split of its common stock, effective August 24, 2026. This is a governance event involving amendment to the company's Certificate of Incorporation. While reverse stock splits are typically routine capital structure adjustments, this one is material because it substantially reduces outstanding shares from approximately 102.3 million to 12.8 million and affects all convertible securities, warrants, options, and RSUs, which would impact investor holdings and market perception.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-19
The 6-K discloses a PIPE transaction (private investment in public equity) involving the issuance of 88,235 Class B ordinary shares at $3.40 per share for $300,000 in aggregate proceeds. The transaction closed on August 17, 2026, and the shares were issued in reliance on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This is a classic dilutive equity issuance by a small-cap foreign private issuer raising capital through unregistered securities, fitting the `dilutive_issuance` taxonomy precisely.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-19
OptimumBank Holdings entered into a Subordinated Note Purchase Agreement on August 19, 2026, issuing $35.0 million in aggregate principal amount of 7.50% Fixed-to-Floating Rate Subordinated Notes due 2036. This is a clear creation of a new direct financial obligation disclosed under Item 1.01 and Item 2.03, representing a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-19
Chris Polimeni resigned as Chief Financial Officer effective August 17, 2026, with no disagreement or cause noted. While Stephanie Brady was simultaneously appointed as Chief Accounting Officer and primary financial officer, the filing's primary focus and the Item 5.02 disclosure centers on Polimeni's departure from the CFO role. The appointment is secondary to the departure event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-19
EX-99.1
SKK Holdings announced the award of six new HDD and utility works contracts in Singapore valued at up to US$26.6 million. While the press release emphasizes this as "the largest block of new work the Company has announced to date," the disclosure is fundamentally a contract award announcement—an operational business development event. The contracts are independent of the pending Rantizo acquisition and represent ongoing work in the Company's core subsurface utility business. This is material to investors as it demonstrates the strength of the operating foundation and revenue pipeline, but it is not a discrete event type (earnings, M&A, impairment, etc.) and therefore fits best under operational_other.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-19
The filing discloses multiple compensatory arrangements for named executives and directors: (1) a stock option exchange effective July 24, 2026, converting 1,319,394 options to RSUs for Brian Carrico (199,188 RSUs), Adrian Miranda (199,106 RSUs), and Thomas Carrico (193,678 RSUs) with immediate vesting; (2) RSU grants on August 13, 2026, to four named executives (Carrico, Henrichs, Miranda, Carrico) vesting over three years; and (3) one-time equity awards of 127,120 shares to independent directors. These are material compensatory arrangements affecting executive and director compensation under the 2022 Plan.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-19
The filing discloses adoption of an amended and restated Employee Retention Plan and Retention Agreement on August 14, 2026, establishing compensatory arrangements for eligible employees including retention incentives tied to Change in Control events and salary increases during Insolvency periods. This is a material disclosure of executive and employee compensation arrangements under Item 5.02(e), distinct from a departure or appointment.
View raw filing on EDGAR →
8-K
Governance Other
confidence 92%
filed 2026-08-19
The filing discloses a 1-for-20 reverse stock split of AiRWA Inc.'s common stock, effective August 17, 2026, pursuant to stockholder approval at the April 2026 annual meeting. Item 5.03 explicitly covers amendments to articles of incorporation and bylaws. While a reverse split is a capital structure event, it is fundamentally a governance/corporate action that modifies the company's capitalization structure and is material to investors assessing share ownership and market dynamics, though it does not fit the specific financial or operational event categories in the taxonomy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-19
The 6-K discloses the appointment of multiple new directors and officers effective August 19, 2026, including the appointment of Li Xiang and Liu Zhenyu as Independent Directors, and the continuation of Huang Hongwu as CEO/Chairman and Wang Xuefei as CFO. While two directors (Wang Zhiyong and Zhang Peng) also resigned, the principal disclosed action is the appointment of new board members and the restructuring of executive leadership, which is material to investors' assessment of governance and management continuity.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-19
Item 8.01
The Board of Directors approved and declared a cash dividend of $0.25 per share of Class A common stock and $2.50 per share of Class B common stock, payable on September 1, 2026. This is a routine but material dividend declaration that affects shareholder returns and is disclosed via press release as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-19
Item 3.02
The Company issued 575,800 shares of common stock (103,800 + 172,000 + 300,000) in unregistered transactions to existing preferred stockholders in exchange for retirement of preferred shares. This is a classic dilutive issuance under Item 3.02, relying on Section 3(a)(9) exemption. The aggregate issuance is material in size and dilutes existing common shareholders without cash proceeds to the Company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-19
Item 5.02
Freddie Deutsch, Director of Specialty Business Lending and board member of both the Company and the Bank, is retiring effective January 15, 2027. The filing discloses his voluntary departure from his officer position and board seats, along with a Letter Amendment to his Employment Agreement governing the transition. While the disclosure also addresses compensatory arrangements (retention bonus, equity treatment, health coverage), the principal disclosed action is the executive's departure from his roles, making exec_departure the most salient classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-19
Item 8.01
News Corporation disclosed daily buy-back notifications under its $1 billion repurchase program authorized July 15, 2025, with approximately $433.7 million already deployed as of August 19, 2026. The Item 8.01 disclosure covers ongoing share repurchases for both Class A and Class B common stock, which constitute a return of capital to shareholders. While the exhibits show routine ASX compliance filings, the core event is the company's execution of its shareholder-value-enhancing repurchase program, classifiable as a dividend_distribution (share repurchase variant).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-08-19
Item 2.03
SAIC entered into Amendment No. 6 to its Master Accounts Receivable Purchase Agreement with MUFG Bank, increasing the facility limit from $300 million to $400 million for sale of eligible U.S. government receivables, thereby creating or expanding a direct financial obligation.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-19
Item 5.02
Seven directors resigned from the Board of Internet Sciences Inc. between August 14–16, 2026, all effective immediately. The Item 5.02 disclosure centers on the departure of these board members (Michael Kahn, Dimitrius M. Hutcherson, Keith R. Wyche, Dr. Mark T. Maybury, James C. Forbes, Mark Deutsch, and Debra Bigman). None cited disagreement with the Company, though some cited time constraints or other board commitments. The near-simultaneous mass departure of a substantial portion of the board is material to investors' assessment of governance stability and continuity.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-08-19
Item 8.01
Aurinia announced a settlement agreement with Teva resolving patent infringement litigation over voclosporin generic entry. The settlement stipulates validity and enforceability of two key patents expiring in December 2037 and grants Aurinia market exclusivity until December 7, 2036. This is a material litigation settlement that directly affects the company's ability to protect its lead commercial product (LUPKYNIS/voclosporin) from generic competition, a core business asset for a biopharmaceutical company.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-08-19
Item 1.01
Weave Communications entered into an Agreement and Plan of Merger with Francisco Partners affiliates on August 18, 2026, providing for acquisition of the Company at $7.40 per share in cash. The disclosure details the merger structure, consideration, equity treatment, closing conditions, and stockholder approval requirements—all hallmarks of a material acquisition transaction requiring Item 1.01 disclosure. This is a change-of-control event that would materially affect investor assessment of the registrant.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-19
EX-99.1
This exhibit is a press release announcing Flex LNG's unaudited financial results for the second quarter 2026 (quarter ended June 30, 2026), dated August 19, 2026. It discloses vessel operating revenues of $106.8 million, net income of $44.9 million, earnings per share of $0.83, and provides forward guidance for full-year 2026 revenue ($345–$370 million) and adjusted EBITDA ($255–$280 million). The document also announces a quarterly dividend of $0.75 per share. This is a discrete earnings announcement, not a periodic financial report, and the results are material to investors assessing the registrant's financial performance and cash generation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-19
Item 7.01
The Board letter discloses multiple governance and strategic actions: elimination of earnout shares for management and directors, parent-level cost reductions, strategic alternatives for subsidiaries, and management realignment. While the letter addresses shareholder concerns and includes operational restructuring (workforce reduction, cost cuts), the primary focus is on governance actions (earnout forfeiture, board-level strategic decisions) and capital allocation rather than a single discrete event type. The earnout forfeiture is a governance matter affecting executive compensation, but the letter's breadth—spanning strategic alternatives, funding transitions, and cost reductions—makes it primarily a governance disclosure addressing multiple shareholder concerns simultaneously.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-19
Item 8.01
The filing discloses the grant of U.S. Patent No. 12,711,989 for VuLink®'s automatic cross-activation and synchronized recording technology, which extends the Company's intellectual property portfolio acquired through the Digital Ally acquisition. While this is a product/technology milestone rather than a traditional M&A event, it is material because it strengthens competitive positioning and customer retention across the 800+ law enforcement clients acquired in the August 3, 2026 Digital Ally transaction, directly supporting the strategic rationale for that acquisition.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-19
Item 8.01
Curtiss-Wright announced a $100 million expansion of its 2026 share repurchase program, implemented via a Rule 10b5-1 trading plan. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The filing explicitly states this is part of the company's disciplined approach to "long-term value creation for our shareholders," and the CEO emphasizes the Board's confidence in the company's financial outlook, making this material to investors assessing capital allocation strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-19
Item 2.02
Carlyle Credit Income Fund issued a summary press release and detailed earnings presentation on August 19, 2026, announcing third quarter 2026 financial results. The disclosure includes key metrics such as net investment income per share ($0.07 GAAP, $0.09 adjusted, $0.25 core), net asset value per share ($3.32), and total fair value of investments ($118.9 million), along with dividend declarations. This is a standard quarterly earnings release filed under Item 2.02, material to investors assessing the fund's financial performance and dividend sustainability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-19
Item 2.02
BILL Holdings issued a press release on August 19, 2026 disclosing financial results for the fourth quarter and fiscal year ended June 30, 2026. The disclosure includes detailed revenue metrics (FY26 total revenue of $1.7 billion, up 13% YoY; core revenue of $1.5 billion, up 16% YoY), profitability measures, and forward guidance for Q1 and FY27. The press release is furnished as Exhibit 99.1 and represents a standard earnings announcement with both GAAP and non-GAAP reconciliations, typical of Item 2.02 disclosures.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-19
Item 5.02
Mark A. Chiplock resigned as Executive Vice President, Chief Financial Officer and Chief Accounting Officer of Ameresco, Inc., effective September 25, 2026, to pursue other professional opportunities. The company has begun a search for a replacement and reaffirmed its financial guidance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-19
Item 3.02
The Fund sold 627,661 Class I common shares for $16.7 million during August 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-19
Item 8.01
The Fund declared and paid regular monthly distributions to shareholders across multiple share classes (Class I, S, and D) for August through December 2026, with specific per-share amounts and payment dates.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-19
Item 5.02
Zhak Cohen, a board nominee of GPC Fund under the Board Nominee Agreement, resigned from the Board effective August 17, 2026, in connection with his departure from Gallatin Point Capital LLC. This is a clear director departure disclosure under Item 5.02, with the principal action being a person leaving the board. The filing explicitly states no disagreement was involved, and the resignation was tied to his employment change at the fund manager.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-08-19
Item 5.02
David J. Corrsin, a long-tenured director and Executive Vice President and General Counsel since the company's 2000 formation, resigned from both his board seat and executive officer position effective August 17, 2026. While he transitions to a Special Legal Advisor role, the principal disclosed action is his departure from formal executive and directorial positions after 26 years of service, making this a material executive departure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-19
EX-99.3
This is a press release announcing Alvotech's financial results for the first half of 2026, including adjusted total revenue of $211.9 million (down 30.8% YoY), adjusted EBITDA of $46.9 million, and cash balance of $142.8 million. The disclosure includes H1 2026 financial highlights, Q2 business highlights (FDA resubmissions, facility inspection results, equity financing), CEO commentary, and full-year 2026 guidance ($650-700M revenue, $180-220M adjusted EBITDA). This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance and regulatory progress.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-19
EX-99.3
This is a half-year financial results announcement for Telix Pharmaceuticals for the period ended June 30, 2026. The exhibit discloses key financial metrics including revenue of US$477 million (up 22% year-over-year), gross margin of 55%, adjusted EBITDA of US$52 million, and profit after tax of US$38 million, along with segment performance and operational milestones. This is a discrete earnings event, not a periodic financial report itself, and would materially affect investor assessment of the company's financial performance and commercial execution.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-19
John Rogers, Chief Financial Officer of Smith & Nephew plc, has announced his resignation effective 30 September 2026 to take up an external position. The disclosure explicitly states he "informed the Board of his intention to leave his position as Chief Financial Officer" and "will step down from the Board with immediate effect." This is a clear executive departure of a named senior officer, material to investors assessing the company's leadership stability and financial oversight.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-08-19
Haleon announces the pricing terms, expiration, and results of a cash tender offer to repurchase $1,999,350,000 of outstanding 3.375% Fixed Rate Senior Notes due March 2027. While this is technically a debt repurchase (reduction of existing debt) rather than issuance of new debt, it represents a material modification of the company's direct financial obligations and capital structure. The tender offer mechanics and pricing announcement constitute a material financial event affecting the registrant's debt profile.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-19
EX-99.1
This is a press release disclosing Medicure's quarterly financial results for the period ended June 30, 2026. The document presents net revenue of $7.4 million, net loss of $1.4 million ($0.14 per share), and adjusted EBITDA of $172,000, along with detailed segment performance and cash position. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and schedules a conference call to discuss results, which are hallmarks of an earnings release event.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-19
Item 8.01
The filing discloses a dividend declaration by the Federal Home Loan Bank of New York's Board of Directors for the second quarter of 2026 at a rate of 6.69% (annualized), with distribution to member financial institutions on August 20, 2026. This is a clear dividend distribution event material to members' assessment of their investment returns in the cooperative.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-19
Item 1.01
The filing discloses entry into a definitive tender offer agreement on August 14, 2026, whereby European Guarantee Services S.à.r.l. agreed to acquire all outstanding shares of Cavitation Technologies for $35 million in cash (less indebtedness and liabilities), representing a change of control transaction. This is a material acquisition/change of control event properly disclosed under Item 1.01, with the press release confirming this is a "monumental milestone" and the combined transaction with Alchemy Beverages totaling $42 million in aggregate consideration.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Focus Universal Inc.'s 2026 annual meeting of stockholders held on August 18, 2026. The filing presents voting results for four proposals: election of five directors, ratification of the independent auditor (Weinberg & Company, P.A.), approval of up to $250 million in securities issuances, and advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-19
This 8-K discloses financial statements and pro forma information of Thramann Holdings, LLC in connection with a definitive merger agreement entered into on February 17, 2026 between Auddia and Thramann Holdings. The filing explicitly states that "Auddia shareholders are expected to own approximately 20% of the combined company at closing" with "Approximately 80% of the combined company is expected to be owned at closing by Jeff Thramann," indicating a material acquisition/change of control transaction. The Rule 425 checkbox is marked, confirming this is written communication in connection with a securities offering related to the merger.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-19
Item 5.02
Shun-Chih Chuang was appointed as Chief Financial Officer effective August 17, 2026, under a new Employment Agreement providing annual salary of $84,000 and 100,000 shares annually.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 72%
filed 2026-08-19
Item 1.01
The company entered into a consulting agreement providing equity compensation of 100,000 shares total (50,000 immediately and 50,000 conditional on continued service through 2027) vesting over two years for strategic advisory services on AI technology.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-08-19
Item 5.07
Item 5.07 requires disclosure of shareholder vote results. Although this filing reports a failed quorum rather than completed voting results, it discloses the outcome of a stockholder meeting submission — specifically that the adjourned Special Meeting on August 19, 2026 lacked the required quorum (1,157,852 shares needed; only 3,473,554 shares outstanding) and was cancelled without further proxy solicitation. This is a material governance event affecting the Company's ability to conduct shareholder business.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-19
Item 8.01
BayCom Corp's Board of Directors declared a quarterly cash dividend of $0.30 per share, payable on October 8, 2026, to shareholders of record as of September 10, 2026. This is a straightforward dividend distribution disclosure, which is material to shareholders as it represents a return of capital and signals the company's capital allocation policy and financial health.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-19
Item 7.01
The filing announces the appointment of Tony Fabrizio as Director, Aerospace and Defense of VisionWave Holdings UK Ltd, a wholly-owned subsidiary. Although the position is at the subsidiary level rather than the parent company, Fabrizio is described as leading business development and sales activities across the United Kingdom and Europe as part of the Company's strategic expansion into international defense and aerospace markets. His 25+ years of defense sector experience and direct role in executing the Company's geographic expansion strategy make this a material executive appointment warranting disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-19
EX-99.1
This is a press release announcing Opera's second quarter 2026 financial results, with revenue of $178.1 million (25% YoY growth) and adjusted EBITDA of $42.4 million (32% YoY growth), both exceeding guidance ranges. The release includes detailed financial statements, business highlights, and updated full-year 2026 guidance. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-19
EX-99.1
This is a press release announcing Viking Holdings Ltd's second quarter 2026 financial results, including revenue of $2,190.5 million (up 16.5% YoY), Adjusted EBITDA of $748.4 million (up 18.2% YoY), and Diluted EPS of $1.31. The exhibit includes consolidated interim financial statements (income statement, balance sheet, cash flows) and detailed operational metrics. This is a classic earnings release disclosing quarterly financial performance and is material to investors assessing the registrant's financial condition and operating trends.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-19
EX-99.1
NuRAN completed a private placement of 1,788,233 Series A convertible preferred shares for $7.6 million aggregate consideration, with $3 million in cash and the balance satisfied through settlement of convertible debt, accrued salary, and accounts payable. The issuance includes 200,000 A warrants and 1,588,233 B warrants, creating significant dilution to existing shareholders. This is a classic dilutive equity issuance by a small-cap company raising capital through unregistered securities, with related-party participation by the CEO, CFO, and CTO.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The Compensation Committee approved compensatory arrangements for two named executives: a $200,000 base salary increase and $10 million in special equity awards (RSUs and PSUs) for CEO Paul Keel, and a $1.5 million performance-based equity award for CFO Eric Hammes.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-19
Item 8.01
The Board appointed Paul Keel, the Company's President and CEO, to serve as Chair of the Board effective August 19, 2026, and concurrently appointed Scott Huennekens as Lead Independent Director, representing a material governance restructuring of board roles and leadership structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
On August 17, 2026, the Compensation Committee approved a special grant of 880,000 performance-based, price-vesting restricted stock units to Matthew Bromberg, the Company's President and CEO, as a one-time supplemental performance award contingent on continued service and substantial stock price appreciation.
View raw filing on EDGAR →